Ly-49J Activators
Ly-49J Activators consist of a diverse range of chemical compounds that indirectly enhance the functional activity of Ly-49J, a key receptor in natural killer (NK) cells, through various signaling pathways. Epigallocatechin gallate, by inhibiting protein tyrosine kinases, relieves the competitive inhibition on pathways vital for Ly-49J-mediated cytotoxic responses, thereby potentiating its function in NK cells. Forskolin, through the elevation of cAMP and subsequent activation of PKA, influences phosphorylation events that are essential for boosting Ly-49J signaling and NK cell cytotoxicity. Sphingosine-1-phosphate and Thapsigargin, by modulating lipid signaling and increasing intracellular calcium levels respectively, create an intracellular milieu favorable for Ly-49J activation. PMA, as a PKC activator, and the MAPK pathway modulators U0126 and LY294002, further enhance Ly-49J function by tweaking phosphorylation patterns and signaling cascades that are integral to NK cell activation and the robust functioning of Ly-49J.
Additionally, the narrative of Ly-49J activators includes compounds that modulate broader cellular processes but have specific implications for Ly-49J activity. Wortmannin, another PI3K inhibitor, and Rapamycin, an mTOR inhibitor, adjust cellular signaling in ways that indirectly support Ly-49J function, primarily by affecting pathways crucial for NK cell activation and response. Staurosporine, with its broad kinase inhibition profile, may selectively influence kinase-dependent regulatory mechanisms, thus enhancing Ly-49J-mediated responses. Zoledronic acid, by impacting prenylation pathways, subtly adjusts the localization and activation of proteins involved in Ly-49J signaling. Lastly, Ionomycin, by raising intracellular calcium levels, activates calcium-dependent pathways that are critical for the effective functioning of Ly-49J in NK cells. Collectively, these activators work in concert to create a biochemical environment that bolsters the activation and functionality of Ly-49J in natural killer cells, enhancing immune surveillance and cytotoxic responses.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This compound inhibits protein tyrosine kinases, indirectly enhancing Ly-49J function in natural killer cells by alleviating competitive signaling from tyrosine kinase pathways, thus facilitating Ly-49J-mediated cytotoxic responses. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule modulates sphingosine-1-phosphate receptors, indirectly enhancing Ly-49J's role in immune surveillance by influencing the migration and localization of natural killer cells, critical for Ly-49J function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
As a SERCA pump inhibitor, Thapsigargin elevates intracellular calcium levels, which can potentiate Ly-49J signaling pathways in natural killer cells by activating calcium-dependent proteins involved in cytotoxic response. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, indirectly enhancing Ly-49J's role in natural killer cell activation and cytotoxicity by promoting phosphorylation events that facilitate Ly-49J-mediated immune responses. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK1/2 inhibitor, U0126 indirectly supports Ly-49J function by shifting the equilibrium of MAPK signaling, thereby promoting pathways involved in natural killer cell activation and enhancing Ly-49J-mediated responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 indirectly augments Ly-49J activity by modulating AKT signaling, thus promoting pathways that enhance the functional activity of Ly-49J in natural killer cells. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, Wortmannin indirectly enhances Ly-49J activity by altering AKT signaling pathways, which are critical for the activation and function of Ly-49J in natural killer cells. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
This mTOR inhibitor indirectly supports Ly-49J function by modulating cellular metabolism and immune responses, which are essential for the optimal activity of Ly-49J in natural killer cells. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
As a broad-spectrum protein kinase inhibitor, Staurosporine indirectly modulates various signaling pathways, potentially enhancing Ly-49J-mediated cytotoxic responses by affecting kinase-dependent regulatory mechanisms in natural killer cells. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
This bisphosphonate inhibits farnesyl pyrophosphate synthase, indirectly enhancing Ly-49J function by modulating prenylation pathways crucial for the localization and activation of proteins involved in Ly-49J signaling. | ||||||